STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and more

Summary

Vertex Pharmaceuticals will acquire Crinetics Pharmaceuticals for $10 billion to add a drug for a rare endocrine disorder to its portfolio.